CEACAM1 and neoplasm: We further sought to validate the expression of two adhesion molecules at the protein level using flow cytometry: CEACAM1, a tumor marker [75] and broad inhibitor of T-cell function [76] and MCAM, a Th17 marker [77] and regulator of cell recruitment into the brain [78].